Member Info for StarKnight

minge

You are as thick as PIG SHHIITT they were comparing the ups and downs of the SP you KN0BB HEAD

minge

you have missed the 5 off from the front of your message of 40p it will be 540p by close of play today

Whatsoccurring

I'll tell you whatsoccuring ! You a a 5h1t Head ! You obviously do not like this share so P155 OFF from this board as you are just another idiotic brain dead de ramper

2.8 million buy !!! its GONNA BLOW Get in while you can !

Do not worry about the SP drop ! All shares go up and down ! This will multi bag its kids selling out that have not seen the RNS yet ! when they do they will kick themselves

Cando yeah they are just T055ers

POST POST POST

POST POST POST TO AS MANY NEWS AGENCIES AS YOU CAN

Cheers Fig

Can everyone else send the copies of the RNS to every news agency they can think of ? the more this news gets oy the higher the SP will go here is the link copy and paste away

https://www.londonstockexchange.com/news-article/BRH/further-update-re-paraytec-limited/14881592

Well I have sent a copy of the RNS to BBC NEWS, SKY NEWS AND REUTERS

Sit back relax and wait for the multi bagger times to roll in

RNS in full GLOBAL PRODUCTION THIS IS MASSIVE

Braveheart Investment Group plc

("Braveheart" or the "Group")

Further update re Paraytec Limited

Further to the announcements on 29 January 2021, Braveheart Investment Group plc (AIM: BRH), is pleased to provide an update concerning progress to develop a COVID-19 test that Paraytec Limited ("Paraytec" or the "Company") is working on in conjunction with the University of Sheffield.

Testing of the first 500 samples being provided by Sheffield Hospitals Trust has been a key focus of the Paraytec team's work in the last month. The clinical sample pipeline is now fully operational.

Samples are being processed and subjected to analysis using Paraytec's photonics-based detection system. The average time to acquire test results is currently less than 120 seconds, a market-leading value. The laboratory trials data confirm the performance of Paraytec's photonics-based test in identifying patients with an infectious viral load within the acceptable range specified by MHRA.

The current gold standard for estimation of viral load continues to be laboratory-based PCR tests. However, these detect viral RNA levels and not necessarily the presence of infectious virions, which means that many patients test positive, long after they are no longer infectious. Paraytec has thus adopted an additional comparator test developed by the University of Sheffield, to verify the presence of intact virus particles. This involves ultracentrifugation and high-resolution fluorescence microscopy to independently verify the presence of virions in clinical samples.

In parallel to the sample processing described above, the Paraytec team has been using isolated lab-grown virus to optimise the operational sensitivity of its instrument for the detection of pre-symptomatic and early-stage symptomatic virus levels. It believes it will be able to confirm, within a period of four weeks, a lower limit of detection of 1,000 virions per millilitre of sample, also a market-leading value.

Paraytec will complete additional analysis of samples in the clinical pipeline in order to acquire robust statistical data and prepare the detailed technical specification required by regulators and producers. The team believes that the high speed and high sensitivity of its test may enable the undertaking of multiplexed "matrix" testing. Matrix testing combines samples from multiple people for simultaneous analysis, such that 20 parallel tests can yield individual results for up to one hundred people. Such a test would be very helpful to the successful operation of large events, like sports or music festivals.

Paraytec will now progress to a prospective clinical validation with a larger number of patient samples and seek to obtain a CE mark for the test. Depending on location, the prospective clinical trial (where individual patient outcomes are monitored over time) is expected to take two months to complete and a further update is

Yes get everyone up to speed at the weekend and maybe a BLOCKBUSTER RNS AT 7am Monday morning !! Or Intra day RNS to coincide with NASDAQ

The interview was recorded on 1st February 2021 !!! So how come it’s only just being aired now at the end of February ?
No news on Accustem !!!

Yeah I saw that I just set my box to record Bloomberg from 5 to 7 pm just to be sure would of been better to state whether it was GMT or not

Time could be 5pm in U.K. as Europe is 1 hour ahead

Don’t forget Dr Kunwar interview today Sunday at 6 pm

Friday 26 February, 2021
Tiziana Life Sciences Plc
Tiziana Life Sciences Interview to Air on Bloomberg Television US on The RedChip Money Report
NEW YORK and LONDON, Feb. 26, 2021 (GLOBE NEWSWIRE) -- Tiziana Life Sciences (NASDAQ: TLSA; LSE: TILS), a biotechnology company focused on innovative therapeutics for oncology, inflammation, and infectious diseases, today announced that an interview with its CEO, Dr Kunwar Shailubhai, will air on The RedChip Money Report on Bloomberg Television on Saturday, February 27, 2021 at 7 p.m. local time across the United States and on the Bloomberg Network in Europe on Sunday, February 28, 2021 at 6 p.m. local time. The RedChip Money Report airs on Bloomberg Television U.S. on Saturdays at 7 p.m. local time in 73M homes and on the Bloomberg Network in Europe in 100M homes at 6 p.m. local time on Sundays.

In the exclusive interview, Dr Shailubhai discusses topline data from Tiziana’s COVID-19 trial, its multiple Phase 2 trial launches expected in 2021, and the potential application of Foralumab in a wide range of autoimmune and inflammatory diseases.

“The RedChip Money Report" delivers insightful commentary on small-cap investing, interviews with Wall Street analysts, financial book reviews, as well as featured interviews with executives of public companies.

Har ha ha ha ha absolutely ;-}

Cannot buy must be NT

SP 112 Started moving up al last plus Nasdaq TILST is up in Pre Market
3.060 +0.080 +2.685%

Yes so am I especially with the SP being so low already. This is actually good news !

Looks like we are in a good position to go forward......I like this part of the RNS....The Company has been further assured by our Broker and Subscriber Warrant Shareholders that the exercised shares are held by long term shareholders with no party having an immediate intention of disposal.